RETRACTION: SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically (Retraction of Vol 24, Pg 261, 2016)MOLECULAR THERAPYIF122023-05-010OA
RETRACTION: Inflammatory-Related P62 Triggers Malignant Transformation of Mesenchymal Stem Cells through the Cascade of CUDR-CTCF-IGFII-RAS Signaling (Retraction of Vol 11, Pg 367, 2018)MOLECULAR THERAPY-NUCLEIC ACIDSIF02023-03-010OAAI
miR675 Accelerates Malignant Transformation of Mesenchymal Stem Cells by Blocking DNA Mismatch RepairMOLECULAR THERAPY-NUCLEIC ACIDSIF02019-03-017OAAI
Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15aMOLECULAR CANCERIF33.92018-06-12174OAAI
miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1MOLECULAR THERAPY-NUCLEIC ACIDSIF02018-06-0122OAAI
RETRACTED: Inflammatory-Related P62 Triggers Malignant Transformation of Mesenchymal Stem Cells through the Cascade of CUDR-CTCF-IGFII-RAS Signaling (Retracted article. See vol. 31, pg. 13, 2023)MOLECULAR THERAPY-NUCLEIC ACIDSIF02018-06-018OAAI
Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTENCELL DEATH & DISEASEIF9.62018-02-15103OAAI
Inflammatory cytokine IL6 cooperates with CUDR to aggravate hepatocyte-like stem cells malignant transformation through NF-κB signalingSCIENTIFIC REPORTSIF3.92016-11-1122OAAI
HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2SCIENTIFIC REPORTSIF3.92016-10-2674OAAI
RETRACTED: SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically (Retracted article. See vol. 31, pg. 1496, 2023)MOLECULAR THERAPYIF122016-02-0143OA
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项